<table id="ID65" width="101%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2. Efficacy Data From US Phase III Trials</caption>
<col width="32%"></col>
<col width="12%"></col>
<col width="22%"></col>
<col width="13%"></col>
<col width="22%"></col>
<tfoot>
<tr>
<td align="left" colspan="5">
<paragraph stylecode="Footnote">* p&lt;0.05 versus placebo. <br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="5">
<paragraph stylecode="Footnote">† A successful outcome in terms of clinical disability was defined prospectively<br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="5">
<paragraph stylecode="Footnote">as ability to work mildly impaired or ability to and function normally.  <br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="5">
<paragraph stylecode="Footnote">‡ Includes patients that may have received an additional placebo injection 1 hour<br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="5">
<paragraph stylecode="Footnote">after the initial injection. <br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="5">
<paragraph stylecode="Footnote">§ Includes patients that may have received an additional 6 mg of sumatriptan<br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="5">
<paragraph stylecode="Footnote">succinate injection 1 hour after the initial injection. <br/>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" colspan="1" stylecode=" Lrule Rrule Toprule" valign="top">
<br/>
</td>
<td align="center" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Study 1<br/>
</td>
<td align="center" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Study 2<br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">1-Hour Data<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Placebo<br/>(n = 190)<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Sumatriptan<br/>succinate injection <br/>6 mg<br/>(n = 384)<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Placebo<br/>(n = 180)<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Sumatriptan<br/>succinate injection <br/>6 mg<br/>(n = 350)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Patients with pain relief <br/>(grade 0/1) <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">18%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">70%*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">26%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">70%*<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Patients with no pain <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">5%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">48%*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">13%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">49%*<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Patients without nausea <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">48%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">73%*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">50%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">73%*<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Patients without photophobia <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">23%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">56%*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">25%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">58%*<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Patients with little or <br/>no clinical disability<content stylecode="bold">
<sup>†</sup>
</content>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">34%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">76%*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">34%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">76%*<br/>
</td>
</tr>
<tr>
<td align="center" colspan="1" stylecode=" Lrule Rrule Toprule" valign="top">
<br/>
</td>
<td align="center" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Study 1<br/>
</td>
<td align="center" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Study 2<br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule" valign="top">2-Hour Data<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Placebo<sup>‡</sup>
<br/>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Sumatriptan<br/>succinate injection <br/>6 mg<sup>§</sup>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Placebo<sup>‡</sup>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Sumatriptan<br/>succinate injection <br/>6 mg<sup>§</sup>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Patients with pain relief<br/>(grade 0/1) <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">31%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">81%*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">39%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">82%*<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Patients with no pain <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">11%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">63%*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">19%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">65%*<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Patients without nausea <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">56%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">82%*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">63%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">81%*<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Patients without photophobia <br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">31%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">72%*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">35%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">71%*<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Patients with little or <br/>no clinical disability<content stylecode="bold">
<sup>†</sup>
</content>
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">42%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">85%*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">49%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">84%*<br/>
</td>
</tr>
</tbody>
</table>